Paul Forsyth

It seems PubMed has disappeared. This is the digital equivalent of burning a library.

Senses of belonging & flourishing are vital in the success & fulfilment of a profession

Understanding why these may become inhibited could help increase wellbeing & retention of pharmacists

See our systematic review of the international literature

#PharmSky

www.sciencedirect.com/science/arti...

Alienation and/or anomie in pharmacists: A systematic review and narrative synthesis of the international literature Flourishing and belonging are key concepts for the wellbeing of staff and the success of a profession. Alienation and anomie are distinct types of psy…

Our systematic review of international literature addressing alienation/anomie in pharmacists - led by @pharmacisthf.bsky.social - is now online (open access for 50 days). www.sciencedirect.com/science/arti...

Senses of belonging & flourishing are vital in the success & fulfilment of a profession

Understanding why these may become inhibited could help increase wellbeing & retention of pharmacists

See our systematic review of the international literature

#PharmSky

www.sciencedirect.com/science/arti...

Try this - link to Susan Wolf podcast
philosophybites.libsyn.com/susan_wolf_o...

Link to pharmacy paper
www.sciencedirect.com/science/arti...

Achieving ‘meaning’ in work is complex, involving trying to attain objective endpoints through different subjective duties
podcasts.apple.com/gb/podcast/phi…

Pharmacists mainly agree on the endpoint (patient health) but do we agree on the subjective professional duties & does this matter?
#PharmSky

Fascinating report from the US Surgeon General (“My Parting Prescription for America”), discussing the links between health, community, and fulfillment.

Thanks for flagging it @barrymaguire.bsky.social

www.hhs.gov/sites/defaul...

Patient-reported barriers to medication adherence in heart failure in Scotland AbstractObjectives. Medication adherence is the end result of a complex set of interwoven factors. Non-adherence with medication in heart failure patients

Agreed. Adherence/concordance is typically multi-factorial, so these simplistic one-dimensional interventions interventions only work in a small % of patients. We need to delve into each person’s unique barriers

academic.oup.com/ijpp/article...

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS‐MI) Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardial infarction (MI) are considered to be at risk of progressive adverse cardiac remodelling which can.....

EMPRESS-MI: ‘In patients with left ventricular systolic dysfunction after an acute MI receiving contemporary standard of care, treatment with empagliflozin had no effect on cardiac volumes or LVEF compared with placebo’

onlinelibrary.wiley.com/doi/10.1002/...

This is a great opportunity for pharmacists (or pharmacy technicians) to publish their innovative service models 👇

escpweb.org/escp-best-pr...

Fascinating paper on factors that impact on registration exam passes for UK pharmacists 👀

academic.oup.com/ijpp/advance...

What level of frailty is this paper about? …….. Is the article consistent with this? ……

Soundbites are easy!

1/Medications cause or contribute to
- 8-12% of ED visits
- 37% result in hospitalization

Using ED stats for BC, this is ~279,000 ED visits in BC each year:
- 103,000 hospital admission/year
- Cost upwards of $2 billion/year
The burden on pts & systems is immense!
#medsky #pharmsky #EMsky #GPsky

RPS Fellows List is officially OUT!
819 now 🤩
Congratulations to all Fellow pharmacists who have been successfully nominated.
Happy Friday everyone!
If there’s a friend on the list who you know but haven’t spoken to in a while. Message them & share the joy! #PharmSky
www.rpharms.com/about-us/new...

Assisted dying bill debate: advice to pharmacy professionals The UK chief pharmaceutical officers have given advice to help pharmacists and pharmacy technicians wanting to take part in the assisted dying debate.

My UK chief pharmaceutical officers colleagues & I have provided advice to help pharmacy professionals wanting to take part in the debate on assisted dying. This follows similar advice recently issued to doctors and nurses: www.gov.uk/government/p...

🚨🚨 UK Pharmacy 🚨🚨

Great opportunity for up to £0.5m research funding 👇

www.nihr.ac.uk/funding/rfpb...

Recognition comes in many different forms (eg academic, professional, financial, social etc) and different people likely put different weights on each. But some form of recognition is key to helping most people belong and flourish

Thanks Helen, it’s always really nice to be recognised by your colleagues and peers 😀

#Semaglutide Eligibility Across All Current Indications for US Adults

jamanetwork.com/journals/jam... #MedSky #CardioSky @jamacurrent.bsky.social @novitham.bsky.social @annakatebarton.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social

Twins with heart failure call for end to healthcare 'lottery' Nicole and Farrah live just 32 miles from each other in Northern Ireland, but are in different health trusts.

Time to end the disparity of HF care across the UK. The unfortunate thing is that there are individuals willing to drive that change, but restricted by local politics.

www.bbc.co.uk/news/article...

WOW! So many ☀️ profiles!
Thank you for following me. I’ll do my best to help connect you.
Here’s my starter pack go.bsky.app/PzopiA9
My tips:
🦋 Use starter packs - there’s lots
🦋 Use #Pharmsky in your posts & add to your bio
🦋 Post lots by replies & share content
🦋 Like AND REPOST
🦋 Be kind

Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia | NEJM Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tac...

VANISH2: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

#AHA2024

www.nejm.org/doi/full/10....

Colchicine in Acute Myocardial Infarction | NEJM Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 fac...

CLEAR trial (Part 2): Should we routinely use Colchicine after acute myocardial infarction?

Also no!

#AHA2024

www.nejm.org/doi/full/10....

Routine Spironolactone in Acute Myocardial Infarction | NEJM Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial...

CLEAR trial: Should we routinely use Spironolactone after Acute Myocardial Infarction?

No!

#AHA2024

www.nejm.org/doi/full/10....

UK’s unhealthy food habits cost £268bn a year, report finds Exclusive: Food, Farming and Countryside Commission added up cost to NHS and economy of diet-linked disease

Before the porridge moralists jump in, pls note, that the report found poorer households would have to *double* their food spend to be able to eat a healthy diet.

Poverty sickens society. Raise benefits & minimum wage, for cost effective benefits to society.

www.theguardian.com/politics/202...

Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press...

BPROAD trial: “Among patients with T2 diabetes, the incidence of major CVD events was significantly lower with intensive treatment targeting a systolic blood pressure of <120 mm Hg than with standard treatment targeting a systolic blood pressure of <140 mm Hg”

www.nejm.org/doi/full/10....

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...

SUMMIT trial: “Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity”
www.nejm.org/doi/full/10....

Heart Failure: a HF-rEFerence Guide (4 Nov 2024) Podcast Episode · Clinical Conversations · 04/11/2024 · 51m

An excellent episode from an excellent podcast series
THMs:

In heart failure with congestive AKI diuretics aren’t a nephrotic in to be stopped
Diuretics don’t flog kidneys - they turn off highly energy consuming ion channels so help the kidneys!
podcasts.apple.com/gb/podcast/c...

Tirzepatide for Obesity Treatment and Diabetes Prevention | NEJM Obesity is chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to provide substantial a...

Amazing to see an almost 20% weight reduction with three years of tirzepatide treatment

It would be good though to see government tackle the obesogenic environments in society, so less people required such treatments

www.nejm.org/doi/full/10....